Icagen

Therapeutic antibody discovery company providing diverse antibody repertoires and cutting-edge screening technologies

placeUnited States calendar_todayFounded 2003 groups10 employees language icagen.com

Registered entities

Innovation

74 patent families (56 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace slowing. Cited 4,202 times.

YearFilings
20147
20157
20165
20174
20183
20194
20206
20214
20221
20239
20246
20253

Investor mix

8 investors on record; lead investors include Taglich Brothers.

Investor typeCountShare
Venture capital338%
Private equity225%
Accelerator & incubator113%
Bank & private debt113%
Other / undisclosed113%
Coming soon